Boston Therapeutics, Inc. announced that, on June 4, 2021, Conroy Cheng resigned as an executive officer of the Company. On June 4, 2021, David Ludvigson was appointed to serve as director and, subject to the effective date of the resignation of Mr. Cheng, as the Company's Secretary. Mr. Ludvigson has served as the President and Chief Executive Officer of Nanomix, Inc. since June 2013.